The treatment of IBD includes anti-inflammatory, immunomodulatory and immunosuppressive drugs, in addition to bio-therapy targeting inflammatory cytokines, such as tumor necrosis factor (TNF) or blocking immune cell homing [8]. The gene discussed is TNF; the disease is inflammatory bowel disease.